FDA trims use of contentious Alzheimer’s drug amid backlash
WASHINGTON (AP) — A month after approving a controversial new Alzheimer’s drug, U.S. health regulators on signed off Thursday on…
Tag: Biogen
Medicare copays for new Alzheimer’s drug could reach $11,500
WASHINGTON (AP) — A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the…